A 53-year-old male with clumsiness Leonidas Arvanitis, M.D. Neuropathology Fellow, PGY-6.

Slides:



Advertisements
Similar presentations
Sporadic AD familial AD etiology environmental factors, genetic predisposition etiology oligomerization of A 42 and initial (diffuse) A 42 deposits subtle.
Advertisements

MOTOR NEURON DISEASE The motor neuron diseases (or motor neuron diseases) (MND) are a group of neurological disorders that selectively affect motor neurons.
Medical Mystery Patient X. Symptoms 0 Patient’s Symptoms: 0 Possible Diseases/Disorders: 0 Final Diagnosis:
Loghman hospital – farhad mansouri. IS THE GRAY MATTER INVOLVED? level of conciousness content of conciousness.
Parkinson’s disease: February 19th BIOS E108 Parkin and PINK1
Evaluation of Movement Disorders
MDS-PAS School for Young Neurologists Video Dinner February 21, 2015 Maria Eliza T. Freitas, MD Clinical Fellow In Movement Disorder University of Toronto.
Practical Management of MS in the Primary Care Office Setting Case Study 2.
Parkinson’s Disease Shirley H. Wray, M.D., Ph.D., Professor of Neurology, Harvard Medical School Director, Unit for Neurovisual Disorders Massachusetts.
PHL 437/Pharmacogenomics Fourth Lecture (Parkinson’s disease) By Abdelkader Ashour, Ph.D. Phone:
Part I Mr. Robert Middelton … Over the past few years, he noticed...a slowly developing weakness initially in his hands and arms, now spreading to his.
A 67-year-old male with behavioral and language problems
Module 7.3 Movement Disorders. Parkinson’s Disease A neurological disorder characterized by muscle tremors, rigidity, slow movements and difficulty initiating.
What is Aging? Alzheimer’s Disease Parkinson’s Disease.
Parkinson’s Disease and Treatment Shalla Hanson Medicinal Chemistry April 2009.
931-4 Convergence Insufficiency. History A 73-year old man with known PD for 10 years, complained of horizontal double vision for 18 months. He could.
JP Parkinson’s Disease. Overview Idiopathic PD Clinically and pathologically distinct from other parkinsonian syndromes Degenerative disorder of the CNS.
Introduction to Degenerative Brain Diseases
Amyotrophic Lateral Sclerosis
Case Study 7 Craig Horbinski, M.D, Ph.D.. History 63-year-old male with generalized progressive weakness especially in his lower extremities with difficulty.
Case Study 32 Henry Armah, M.D., M.Phil.. Question 1 Clinical history: 78-year-old white female with history of morbid obesity, hypertension, hypercholesterolemia,
Parkinson’s Disease superKAT :).
Innovations in Parkinson’s Diagnosis & Treatment: A Personal Story Dr. Kenneth E. Keirstead Excellence in Aging Care Symposium September 25-27, 2013.
10 Second Case Studies Round 2: Degenerative Neurological Conditions.
Adult Medical-Surgical Nursing Neurology Module: Parkinson’s Disease.
Case Study 8 Craig Horbinski, M.D., Ph.D.. Clinical history: 45-year-old white female with type I diabetes mellitus starting at age 13, complicated by.
Lananh Nguyen, M.D. Division of Neuropathology University of Pittsburgh Medical Center 24 year old male found unconscious.
Case Study 84 Leonidas Arvanitis, MD
Select Neurodegenerative Diseases. Alzheimer’s Disease.
Teaching NeuroImages A 54-year-old man with progressive muscle weakness, hand tremor, tongue and perioral fasciculation Neurology Resident and Fellow Section.
By Katelyn Chaimson and Sean Guyot
Huntington’s disease By Colten Appleby Kristian Nee Nick Reynoso Please check the notes section for additional information Mrs. GM Period 8 2/8/11.
Α-synuclein transgenic mouse models of Parkinson’s disease Michelle Maurer December 2015.
Parkinson’s Disease Sheila Mulhern. Parkinson’s Disease Stats (PDF)  One million Americans live with Parkinson's disease, - more than the combined number.
Case Study 47 Julia Kofler, M.D.. Clinical history: The patient is a 67-year-old female with >6 months history of weakness, mostly in proximal muscles.
PARKINSON’S DISEASE Jeanette J. Norden, Ph.D. Professor Emerita Vanderbilt University School of Medicine.
Pathogenesis and pathology of parkinsonism
Used to be called Dementia Neurocognitive Disorders.
CPC #7: Pathology Barbara J. Crain, MD, PhD February 25, 2009.
Huntington’s Disease Facts & Information By Matthew Cannon.
Case Study 1 Harry Kellermier, M.D.. Question 1 This is a 70 year-old male who presented with paresthesias and clumsiness in his right upper extremity.
Amyotrophic Lateral Sclerosis (ALS). Also know as Lou Gehrig's Disease Named after the New York Yankees baseball star who played first base and was diagnosed.
How is Parkinson’s disease Diagnosed? And What Are the Treatment options?
Direct motor pathway Corticospinal pathway. Motor Units – Large Versus Small Text Fig
“HEALTH IS THE BEST” In the name of God. WHAT IS IT? Parkinson's disease (PD) is a chronic and progressive movement disorder, meaning that symptoms.
Direct motor pathway Corticospinal pathway.
Genetic disorders. SICKLE CELL ANEMIA CODOMINANT RBC appear sickle-shaped and reduced ability to carry oxygen The 11th pair of chromosomes contains a.
DISORDERS OF THE MOTOR SYSTEM
The Malfunctioning Mind: Degenerative Diseases of the Brain
Idiopathic Parkinson disease
Module 7.3 Movement Disorders
Degenerative brain disease
Falon Fiorillo & Breeanna Fournier
Case Study 29 Julia Kofler, M.D..
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
III. Parkinson Disease.
Alpha-synuclein in Parkinson's disease
Case Study 88 Leonidas Arvanitis, MD
65 year-old female who collapsed at home
Case Study 85 Leonidas Arvanitis
Case Study 87 Leonidas Arvanitis, MD
A 57-year-old male who was brought to the ER unresponsive
What do your chromosomes look like?
Case Study 86 Leonidas Arvanitis, MD
Mark S. Forman, Virginia M-Y. Lee, John Q. Trojanowski  Neuron 
Parkinson's Disease Neuron
Neurodegenerative diseases
Case Study 83 Leonidas Arvanitis, MD
Introduction to degenerative brain disease
Postmortem Neurological Diagnosis A Postmortem Neurological Diagnosis or Brain-Only Autopsy, is the only definitive answer for families or researchers.
Presentation transcript:

A 53-year-old male with clumsiness Leonidas Arvanitis, M.D. Neuropathology Fellow, PGY-6

History The patient was a 53 year male with a 10 year history of clumsiness He initially presented with deterioration of his singing voice, clumsiness of his left hand, incoordination and spastic reflexes. The patient had no history of drug abuse or environmental exposure. An MRI of the brain was normal, but a cervical MRI revealed a small syrinx below C6-7.

History His symptoms progressed, notable for masked facies, increased muscle upper extremity muscle tone, and poor gait and arm. One year before death the patient was also noted to have dementia, the latter manifesting in cognitive difficulty, paranoia, and delusions, but improving with medications.

Autopsy An autopsy was performed and showed the following (describe midbrain section): th/CNSHTML/CNS102.html Our case Normal control

Autopsy th/CNSHTML/CNS102.html Our caseNormal control Marked pallor of substantia nigra

This is a section from the midbrain. What do you see? Midbrain. (Click here for H&E)here

This is a section from the midbrain. What do you see? Midbrain. (Click here for H&E)here

This is a section from the midbrain. What do you see? Midbrain. (Click here for H&E)here Eosinophilic cytoplasmic inclusions Decreased numbers of pigmented neurons

This is a section from the midbrain. What do you see? Midbrain. (Click here for H&E)here Pigmented-laden macrophages Reactive gliosis

Question: The intracytoplasmic neuronal inclusions are known as …

Answer …Lewy bodies

Question: Which immunohistochemical stain highlights the Lewy bodies?

Answer A-synuclein –Click here to view stainhere

Lewy bodies (a-synuclein)

Question What is the diagnosis?

Answer Parkinson’s disease

Question What is the most common cause of Parkinson’s disease?

Answer Most cases are sporadic of unknown etiology Environmental factors such as toxic exposure, infection or lifestyle have been proposed

Question Are there any gene mutations linked to Parkinson's disease?

Answer Yes. Autosomal dominant and recessive mutations –Autosomal dominant include PARK1 point mutation in a-synuclein gene and PARK5 point mutation in ubiquitin carboxyterminal hydrolase-L1 (UCH-L1) –Autosomal recessive include PARK2 mutation in the parkin gene

files/individual%3Agenetic-etiology-of- parkinson-s-disease/img2.JPG